Enanta Pharmaceuticals to Participate in september Investor Conferences
WATERTOWN, Mass.–(BUSINESS WIRE)–Enanta Pharmaceuticals,Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company focused on developing small molecule drugs for viral infections and immunological diseases, announced today that its management team will participate in three investor conferences in September.
- September 5,2025: H.C. Wainwright 27th Annual Global Investment Conference in New York City. Enanta’s CEO, Jay Luly, will present at 1:30 PM ET. Learn more.
- September 10, 2025: Morgan Stanley Healthcare Conference in New York City. Management will host meetings with investors throughout the day. Register for the conference.
- September 12, 2025: Citi Global Healthcare Conference in New York City. Enanta’s CFO, Caroline Beck, will present at 10:30 AM ET. View conference details.
Thes conferences offer valuable opportunities for investors to learn more about Enanta’s pipeline and strategy. The presentations and meetings will cover recent clinical data,ongoing programs,and the company’s future outlook.
About Enanta
Enanta Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to delivering innovative, oral small molecule therapies against viral infections and immunological diseases. Thier research focuses on developing best-in-class treatments with the potential to improve patient outcomes. Visit Enanta’s website for more facts.